search
Back to results

Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Myanmar

Primary Purpose

Plasmodium Falciparum Infection

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Personal protection package
Sponsored by
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Plasmodium Falciparum Infection focused on measuring malaria, prevention, vector, migrant, elimination, vivax, falciparum, community-delivered, intervention

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria for states/regions:

  • Capacity of Burnet Institute Myanmar to conduct field implementation
  • Presence of ICMV networks managed by NMCP and HPA
  • High malaria burden
  • High MMP activities
  • Available budget

Exclusion Criteria for states/regions:

  • The township does not have an NMCP or HPA-provided ICMV network
  • The township is not under the administration of NMCP or HPA
  • The township has an ongoing armed conflict at the time of sampling
  • The location of the township is not geographically or politically feasible for the NMCP or HPA staff to conduct regular supervision visits

Exclusion criteria for villages:

  • The village has no malaria cases or API less than 1 in any of the past three years (2018 - 2020)
  • The village has no MMPs
  • The village has no ICMVs actively working in the village
  • The village has a government health facility for malaria services
  • The village has an ICMV program operated by any organizations other than NMCP or HPA

Inclusion Criteria for MMP participants (personal protection package intervention):

  • Currently living in the selected villages/ worksites
  • Being any of the following types of workers: Traditional slash-and-burn and paddy field farming communities visiting their forest farms (commonly ethnic minority groups); Seasonal agricultural laborers; Forest workers in the informal sector (hunters, small-scale gem/gold miners, people gathering forest products (precious timber, construction timber, rattan/bamboo); Transient or mobile camp residents associated with commercial projects (road/pipeline construction, large-scale logging, deep seaport projects, etc.); Formal and informal cross-border migrant workers
  • Aged 18 years and over

Inclusion criteria for the focus group discussion:

• Participants selected purposively from the same cohort of MMPs who have received the personal protection package during the study period

Inclusion criteria for semi-structured interviews with local health stakeholders:

  • Aged over 18 years
  • From different levels of NMCP, EHOs and HPA
  • Basic health staff such as Public Health Supervisors, Midwives, Health Assistants, Township Health Officers and focal person from Township VBDC/NMCP offices
  • Health staff from ethnic health organizations such as medics, doctors and nurses
  • Health staff from HPA such as field supervisor, field office manager, technical officer

Inclusion criteria for semi-structured interviews with ICMVs:

• ICMV participants will be selected purposively from the ICMVs actively working in the selected villages.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    Personal protection package

    Control

    Arm Description

    A personal protection package that includes Long-lasting insecticidal hammock net (LLIHN),insect repellent (DEET), Insecticide-treated clothes (ITC), and mobile and migrant population-tailored behavioural change communication (BCC) package

    No personal protection package

    Outcomes

    Primary Outcome Measures

    Plasmodium spp. infection diagnosed by RDT
    Change in the number of Plasmodium spp. infections detected by RDT per week per village (SD Bioline P.f/P.v)

    Secondary Outcome Measures

    Symptomatic malaria diagnosed by RDT
    Change in the number of symptomatic Plasmodium spp. infections detected by RDT per week per village
    Plasmodium spp. infection as determined by polymerase chain reaction (PCR)
    Change in the number of Plasmodium spp. infections as determined by PCR using from RDT cassettes and dried blood spots
    Plasmodium spp. drug resistance mutations
    Prevalence and change in the number of Plasmodium spp. drug resistance mutations as determined by PCR from RDT cassettes and dried blood spots
    Prevalence of antibodies to Plasmodium spp.
    Prevalence of antibodies to Plasmodium spp. determined by Enzyme Linked Immunosorbent assay (ELISA) from RDT and DBS samples
    Levels of antibodies to Plasmodium spp.
    Levels of antibodies to Plasmodium spp. determined by Enzyme Linked Immunosorbent assay (ELISA) from RDT and DBS samples
    Prevalence of antibodies to vector salivary antigens
    Prevalence of antibody biomarkers of vector exposure determined by Enzyme Linked Immunosorbent assay (ELISA) from RDT and DBS samples
    Levels of antibodies to vector salivary antigens
    Levels of antibody biomarkers of vector exposure determined by Enzyme Linked Immunosorbent assay (ELISA) from RDT and DBS samples
    Levels of knowledge, attitude and practice regarding malaria prevention among MMPs (qualitative research)
    Focus group discussions
    Proportion of survey respondents (MMPs) who accept and are willing to use/ did use the personal protection package according to the protocol
    Focus group discussions; Questionnaire

    Full Information

    First Posted
    August 16, 2021
    Last Updated
    November 2, 2021
    Sponsor
    Macfarlane Burnet Institute for Medical Research and Public Health Ltd
    Collaborators
    Health Poverty Action, National Malaria Control Program, Myanmar
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05025761
    Brief Title
    Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Myanmar
    Official Title
    A Personal Protection Package for Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Myanmar: A Stepped-wedge Trial With Nested Mixed-methods Study
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 2021
    Overall Recruitment Status
    Unknown status
    Study Start Date
    January 1, 2022 (Anticipated)
    Primary Completion Date
    June 2022 (Anticipated)
    Study Completion Date
    June 2022 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Macfarlane Burnet Institute for Medical Research and Public Health Ltd
    Collaborators
    Health Poverty Action, National Malaria Control Program, Myanmar

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    This stepped-wedge cluster-randomized controlled trial with nested mixed methods study will assess the effectiveness, acceptability, feasibility and cost effectiveness of a personal protection package to reduce malaria transmission among mobile and migrant populations (MMPs) and the general population in their residing villages in Myanmar.
    Detailed Description
    Over the last decade, the burden of malaria has fallen dramatically in the Greater Mekong Subregion, with deaths falling by 95% and cases by 76% between 2012 and 2019.The declining malaria burden in GMS has largely been attributed to the deployment of interventions of malaria prevention tools such as long-lasting Insecticidal Nets (LLIN), and widespread availability of rapid diagnostic tests and artemisinin combination therapies. However, residual transmission exists among high risk populations, particularly mobile and migrant populations who enter forests for work. New interventions targetting these high risk groups are needed if countries of the Greater Mekong Subregion are to achieve malaria elimination by 2030. The study will be conducted in malaria endemic areas of Myanmar which have large forest going MMP populations. The aim of the study is to assess the effectiveness, acceptability, feasibility and cost-effectiveness of a personal protection package to reduce malaria transmission among mobile and migrant populations (MMPs) and the general population in their residing villages in Myanmar. The personal protection package includes WHO prequalified long-lasting insecticidal net (LLIN), insect repellent (N, N-Diethyl-meta-toluamide (DEET), insecticide-treated clothes (ITC), and a MMP-tailored behavioural change communication (BCC) package. The study design is a stepped-wedge cluster-randomized controlled trial with nested mixed methods study. The stepped-wedge cluster randomized trial will estimate the effectiveness of a personal protection package provided to forest-going MMPs (the intervention) delivered by village malaria volunteers at the site (village/worksite) level on reducing Plasmodium spp. infections (primary outcome). Whilst the personal protection package will be provided to mobile and migrant populations in each village in a step-wise manner, primary and secondary outcomes relating to malaria testing will be collected in all consenting individuals in the village who present for malaria rapid diagnostic tests, whether they are mobile and migrant people or not. The study will also include investigation of antibody responses to Plasmodium spp. and mosquito vectors and molecular markers of antimalarial drug resistance. The study will be implemented between July 2021 (M1) to June 2022 (M12). The personal protection package for MMPs will be implemented sequentially in a minimum of 100 villages serviced by an ICMV. The villages will be grouped into 11 blocks of 9 villages, with each block transitioned from control phase (before introduction of the personal protection package) to intervention phase (after introduction of the personal protection package) at monthly intervals in random order. This follows an initial one-month baseline period at the start of the study period where all villages will not be exposed to the personal protection package exclusively. For this proposed stepped-wedge cluster randomized controlled study, it is estimated that approximately 30 RDTs per month will be tested in each study site (village/worksite) and there will be 36,000 MMP tests over 12 months in 100 villages/worksites. It will be undertaken yielding a relative minimum detectable difference of 40% in odds of RDT-detectable malaria infection (assuming a village intraclass correlation [ICC]= 0.42 [6]; 5% significance; 80% power and 1% RDT malaria prevalence). For the stepped-wedged cluster randomized trial, both descriptive and primary outcome trial analyses will be performed. In both analyses, sampling weights will be derived and applied in analyses where village selection probabilities are not equal - possible if the achieved number of villages sampled across townships varies. Furthermore, cluster robust standard errors will be used in all descriptive analyses given the complex sampling design. Differences in prevalence of malaria infections will be estimated across intervention and control periods using generalized linear mixed modelling (e.g. logit link function and binomial distribution).

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Plasmodium Falciparum Infection
    Keywords
    malaria, prevention, vector, migrant, elimination, vivax, falciparum, community-delivered, intervention

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Crossover Assignment
    Model Description
    Stepped-wedge cluster-randomized controlled trial (one-way crossover) with nested mixed methods study
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    1200 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Personal protection package
    Arm Type
    Experimental
    Arm Description
    A personal protection package that includes Long-lasting insecticidal hammock net (LLIHN),insect repellent (DEET), Insecticide-treated clothes (ITC), and mobile and migrant population-tailored behavioural change communication (BCC) package
    Arm Title
    Control
    Arm Type
    No Intervention
    Arm Description
    No personal protection package
    Intervention Type
    Other
    Intervention Name(s)
    Personal protection package
    Intervention Description
    The personal protection package will be distributed to mobile and migrant peoples in each village according to the stepped wedge design.
    Primary Outcome Measure Information:
    Title
    Plasmodium spp. infection diagnosed by RDT
    Description
    Change in the number of Plasmodium spp. infections detected by RDT per week per village (SD Bioline P.f/P.v)
    Time Frame
    Assessed weekly, longitudinally over 12 months
    Secondary Outcome Measure Information:
    Title
    Symptomatic malaria diagnosed by RDT
    Description
    Change in the number of symptomatic Plasmodium spp. infections detected by RDT per week per village
    Time Frame
    Assessed weekly, longitudinally over 12 months
    Title
    Plasmodium spp. infection as determined by polymerase chain reaction (PCR)
    Description
    Change in the number of Plasmodium spp. infections as determined by PCR using from RDT cassettes and dried blood spots
    Time Frame
    Assessed weekly, longitudinally over 12 months
    Title
    Plasmodium spp. drug resistance mutations
    Description
    Prevalence and change in the number of Plasmodium spp. drug resistance mutations as determined by PCR from RDT cassettes and dried blood spots
    Time Frame
    Assessed weekly, longitudinally over 12 months
    Title
    Prevalence of antibodies to Plasmodium spp.
    Description
    Prevalence of antibodies to Plasmodium spp. determined by Enzyme Linked Immunosorbent assay (ELISA) from RDT and DBS samples
    Time Frame
    Assessed weekly, longitudinally over 12 months
    Title
    Levels of antibodies to Plasmodium spp.
    Description
    Levels of antibodies to Plasmodium spp. determined by Enzyme Linked Immunosorbent assay (ELISA) from RDT and DBS samples
    Time Frame
    Assessed weekly, longitudinally over 12 months
    Title
    Prevalence of antibodies to vector salivary antigens
    Description
    Prevalence of antibody biomarkers of vector exposure determined by Enzyme Linked Immunosorbent assay (ELISA) from RDT and DBS samples
    Time Frame
    Assessed weekly, longitudinally over 12 months
    Title
    Levels of antibodies to vector salivary antigens
    Description
    Levels of antibody biomarkers of vector exposure determined by Enzyme Linked Immunosorbent assay (ELISA) from RDT and DBS samples
    Time Frame
    Assessed weekly, longitudinally over 12 months
    Title
    Levels of knowledge, attitude and practice regarding malaria prevention among MMPs (qualitative research)
    Description
    Focus group discussions
    Time Frame
    At 12 months
    Title
    Proportion of survey respondents (MMPs) who accept and are willing to use/ did use the personal protection package according to the protocol
    Description
    Focus group discussions; Questionnaire
    Time Frame
    At 12 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria for states/regions: Capacity of Burnet Institute Myanmar to conduct field implementation Presence of ICMV networks managed by NMCP and HPA High malaria burden High MMP activities Available budget Exclusion Criteria for states/regions: The township does not have an NMCP or HPA-provided ICMV network The township is not under the administration of NMCP or HPA The township has an ongoing armed conflict at the time of sampling The location of the township is not geographically or politically feasible for the NMCP or HPA staff to conduct regular supervision visits Exclusion criteria for villages: The village has no malaria cases or API less than 1 in any of the past three years (2018 - 2020) The village has no MMPs The village has no ICMVs actively working in the village The village has a government health facility for malaria services The village has an ICMV program operated by any organizations other than NMCP or HPA Inclusion Criteria for MMP participants (personal protection package intervention): Currently living in the selected villages/ worksites Being any of the following types of workers: Traditional slash-and-burn and paddy field farming communities visiting their forest farms (commonly ethnic minority groups); Seasonal agricultural laborers; Forest workers in the informal sector (hunters, small-scale gem/gold miners, people gathering forest products (precious timber, construction timber, rattan/bamboo); Transient or mobile camp residents associated with commercial projects (road/pipeline construction, large-scale logging, deep seaport projects, etc.); Formal and informal cross-border migrant workers Aged 18 years and over Inclusion criteria for the focus group discussion: • Participants selected purposively from the same cohort of MMPs who have received the personal protection package during the study period Inclusion criteria for semi-structured interviews with local health stakeholders: Aged over 18 years From different levels of NMCP, EHOs and HPA Basic health staff such as Public Health Supervisors, Midwives, Health Assistants, Township Health Officers and focal person from Township VBDC/NMCP offices Health staff from ethnic health organizations such as medics, doctors and nurses Health staff from HPA such as field supervisor, field office manager, technical officer Inclusion criteria for semi-structured interviews with ICMVs: • ICMV participants will be selected purposively from the ICMVs actively working in the selected villages.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Freya JI Fowkes, DPhil
    Phone
    +61385062310
    Email
    freya.fowkes@burnet.edu.au
    First Name & Middle Initial & Last Name or Official Title & Degree
    Win Han Oo, PhD
    Phone
    +951375785
    Email
    winhan.oo@burnet.edu.au

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Myanmar

    We'll reach out to this number within 24 hrs